![]() |
|
|
Vol. 301, Issue 1, 71-76, April 2002
Institute of Pharmacology, Martin-Luther-University of
Halle-Wittenberg, Halle, Germany
In adult rat ventricular cardiomyocytes, noradrenaline exerts dual
effects on protein synthesis: increases via
1-adrenoceptors and decreases via
1-adrenoceptors. Carvedilol and bucindolol are
-blockers with additional
1-adrenoceptor blocking
activities. We studied the effects of carvedilol and
bucindolol on noradrenaline-induced protein synthesis
(assessed by [3H]phenylalanine incorporation) in adult
rat ventricular cardiomyocytes. Radioligand binding studies with
[125I]iodocyanopindolol and [3H]prazosin
revealed that carvedilol had a much higher affinity to
1-adrenoceptors than bucindolol
(
1-/
1-adrenoceptor ratio for carvedilol,
1:2.7; for bucindolol, 1:43). Noradrenaline-evoked increases in
protein synthesis were enhanced by propranolol (1 µM) and
1-adrenoceptor-selective antagonists bisoprolol (1 µM) and CGP 20712A
[1-[2-((3-carbamoyl-4-hydroxy)phenoxy)-ethyl-amino]-3-[4-(1-methyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propranol methanesulfonate] (300 nM). Carvedilol (100 pM-10 µM) inhibited 1 µM noradrenaline-induced increase in protein synthesis with monophasic concentration-inhibition curves independent of whether CGP
20712A was present or not; Ki values for
carvedilol were 5 to 6 nM. In contrast, bucindolol (100 pM-10 µM)
inhibited l µM noradrenaline-induced increase in protein synthesis
with a bell-shaped concentration-inhibition curve; it increased
noradrenaline-induced protein synthesis at 10 nM, although at
concentrations >100 nM it was inhibited. In the presence of 300 nM CGP
20712A or 1 µM propranolol, however, bucindolol inhibited 1 µM
noradrenaline-induced increase in protein synthesis with monophasic
concentration-inhibition curves; Ki values
were 40 to 75 nM. On the other hand, both carvedilol and bucindolol
inhibited 1 µM phenylephrine-induced protein synthesis with
monophasic concentration-inhibition curves;
Ki values were 4 (carvedilol) and 45 nM
(bucindolol). These results indicate that, at low (
-adrenoceptor
blocking) concentrations, bucindolol can enhance noradrenaline-induced
protein synthesis whereas it is inhibited by carvedilol.
This article has been cited by other articles:
![]() |
A. Salameh, S. Krautblatter, S. Baessler, S. Karl, D. R. Gomez, S. Dhein, and D. Pfeiffer Signal Transduction and Transcriptional Control of Cardiac Connexin43 Up-Regulation after {alpha}1-Adrenoceptor Stimulation J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 315 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Galandrin and M. Bouvier Distinct Signaling Profiles of beta1 and beta2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy Mol. Pharmacol., November 1, 2006; 70(5): 1575 - 1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-D. Schluter and K. C Wollert Synchronization and integration of multiple hypertrophic pathways in the heart Cardiovasc Res, August 15, 2004; 63(3): 367 - 372. [Full Text] [PDF] |
||||